Description
For facilities that has provided parenteral or oral uterotonics in the past 3 months, UTMISO indicates whether health workers used the misoprostol tablet to prevent or treat pregnancy-related hemorrhage.
The question associated with this variable was included in the service delivery point questionnaire.
